Annals of Nuclear Cardiology
Online ISSN : 2424-1741
Print ISSN : 2189-3926
ISSN-L : 2189-3926
Volume 7, Issue 1
Displaying 1-17 of 17 articles from this issue
Editor's Page
Special Review Article
  • What Will Be Its Legacy?
    Takashi Kudo
    Article type: Special Review Article
    2021 Volume 7 Issue 1 Pages 3-7
    Published: August 31, 2021
    Released on J-STAGE: August 31, 2021
    JOURNAL FREE ACCESS FULL-TEXT HTML
    The pandemic of Coronavirus disease 2019 (COVID-19) caused a substantial negative impact on patients with cardiovascular disease. The negative impact of the pandemic on daily clinical practices for cardiovascular diseases (CVD) cannot be underestimated. The CVD patients (without COVID-19 infection), whose diagnosis and treatment have been delayed or postponed by the pandemic, are victims of COVID-19. In this context, COVID-19 is a “syndemic” disease. Several studies already revealed that negative changes already occurred in CVD patient management, such as increased in-hospital death, supply shortage of 99mTc/99Mo generator, etc. To clarify the impact of COVID-19 on the management of CVD, a global survey named “INCAPS-COVID” was conducted. This study revealed a substantial reduction (around 50%) of cardiovascular imaging practice in the early stage of the pandemic during March and April 2020. This pandemic has necessitated changes in cardiovascular management practices to adopt this condition. Some of those changes will become the legacy of the pandemic. Possible legacy will be; 1) Use of telemedicine; 2) Shift from exercise to pharmacological stress; 3) Shift from single photon emission computed tomography (SPECT) to positron emission tomography (PET). By adapting and changing to the challenges caused by the COVID-19 pandemic, nuclear cardiology will survive and will rise as an improved cardiovascular practice, even after the pandemic.
Original Articles
  • Moriaki Yamanaka, Shoichiro Takao, Hideki Otsuka, Otomi Yoichi, Saho I ...
    2021 Volume 7 Issue 1 Pages 8-16
    Published: August 31, 2021
    Released on J-STAGE: August 31, 2021
    Advance online publication: June 25, 2021
    JOURNAL FREE ACCESS FULL-TEXT HTML
  • Takuji Toyama, Shu Kasama, Makito Sato, Hirokazu Sano, Tetsuya Ueda, T ...
    Article type: Original Article
    2021 Volume 7 Issue 1 Pages 17-26
    Published: August 31, 2021
    Released on J-STAGE: August 31, 2021
    Advance online publication: June 22, 2021
    JOURNAL FREE ACCESS FULL-TEXT HTML
    Purpose/Method: No studies have reported on prognostic markers in patients with chronic kidney disease (CKD) according to the severity of the disease. Therefore, in this multicenter, prospective trial performed as part of the Gunma CKD SPECT Multicenter Study, we recruited 311 patients with CKD (eGFR <60 min/mL/1.73 m²) including 50 patients on hemodialysis and followed them for 2 years. The study sample underwent stress 99mTc-tetrofosmin SPECT for suspected or possible ischemic heart disease. We evaluated the summed stress score (SSS), summed rest score (SRS), summed difference score (SDS) and cardiac function with electrocardiogram-gated SPECT. Then, we compared the differences in prognostic markers for major adverse cardiac, cerebrovascular, and renal events (MACCRE) between patients with mild CKD (30 min/mL/1.73 m² ≤ eGFR <60 min/mL/1.73 m²; n=184) and those with severe CKD (eGFR <30 min/mL/1.73 m²; n=97).
    Results: Of 281 patients available for analysis, 91 experienced MACCRE. In a multivariate Cox proportional hazards analysis of factors related to MACCRE, in patients with mild CKD the significant prognostic markers were SDS (P=0.002) and end-systolic volume (ESV, P=0.034); and in the patients with severe CKD, they were eGFR (P=0.03) and diabetes-mellitus (DM, P=0.023).
    Conclusions: Our findings indicate that SDS and ESV are significant prognostic markers for MACCRE in patients with mild CKD and eGFR and DM are significant prognostic markers in patients with severe CKD.
  • Franziska Rambow, Denis Gersdorf, Janin Jacobi, Franziska Mathies, Chr ...
    Article type: Original Article
    2021 Volume 7 Issue 1 Pages 27-32
    Published: August 31, 2021
    Released on J-STAGE: August 31, 2021
    Advance online publication: June 07, 2021
    JOURNAL FREE ACCESS FULL-TEXT HTML
    Background: In myocardial gated single-photon emission computed tomography (GSPECT), to differentiate true changes of left ventricular ejection fraction (LVEF) from inherent methodical variability is clinically relevant; however, data about repeatability of GSPECT LVEF in the same patients are rather inconsistent in literature. The aim of this study was therefore to determine repeatability coefficient (RC) of GSPECT LVEF at rest and to investigate the effect of the introduction of processing constraints in left ventricular edge detection.
    Methods: Thirty-five patients referred for one-day myocardial GSPECT stress-rest scan were included. After the routine stress-rest study, patients were completely repositioned on the imaging table for a second rest acquisition using the same acquisition parameters. LVEF was computed using Corridor 4DM software without and with manual alignment of valve plane. Repeatability was assessed using the Bland-Altman method.
    Results: RC of LVEF from unaligned datasets was 7.6% with upper and lower limits of agreement of 7.4% to -7.8%. After valve plane and ventricular long-axis length alignment, RC improved to 3.6% with upper and lower limits of agreement of 3.4% to -3.8%.
    Conclusions: RC using unaligned determination of GSPECT LVEF was comparable to that from previous publications. However, RC using valve plane alignment could be improved to below 4% on 95% confidence level.
  • Takuji Toyama, Shu Kasama, Yusuke Miyaishi, Hakuken Kan, Eiji Yamashit ...
    Article type: Original Article
    2021 Volume 7 Issue 1 Pages 33-42
    Published: August 31, 2021
    Released on J-STAGE: August 31, 2021
    Advance online publication: June 11, 2021
    JOURNAL FREE ACCESS FULL-TEXT HTML
    Purpose/Method: Aliskiren is a direct renin inhibitor that has been reported to be effective for CHF, but the usefulness of combined therapy with carvedilol and aliskiren has not been reported. Forty-four patients with dilated cardiomyopathy (DCM) were randomized into a group receiving add-on therapy with carvedilol plus aliskiren and another group receiving carvedilol alone for 6 months.
    Nuclear imagings with 123I-Metaiodobenzylguanidine (MIBG) and 99mTc-Sestamibi were performed. Exercise capacity using a specific activity scale (SAS) and the New York Heart Association (NYHA) class were evaluated. Cardiac sympathetic nerve activity was evaluated by 123I-MIBG imaging, with the delayed heart-to-mediastinum activity ratio (H/M), delayed total defect score (TDS), and washout rate (WR).
    Results: Combined add-on therapy with carvedilol and aliskiren improved several parameters much more than carvedilol alone (p<0.05) with respect to TDS, ejection fraction (EF), NYHA, SAS on 6 months and the changes in TDS, EF, end-diastolic volume and brain natriuretic peptide (BNP).
    Conclusion: Add-on therapy with carvedilol and aliskiren is more effective than carvedilol alone for improving cardiac sympathetic nerve activity, cardiac function, symptoms, exercise capacity, and brain natriuretic peptide in patients with DCM.
  • A Phantom Study for ECG-gated Myocardial SPECT
    Denis Gersdorf, Franziska Rambow, Reiner Weise, Ivayla Apostolova, Yus ...
    Article type: Original Article
    2021 Volume 7 Issue 1 Pages 43-48
    Published: August 31, 2021
    Released on J-STAGE: August 31, 2021
    JOURNAL FREE ACCESS FULL-TEXT HTML
    Background: The voxel size in ECG-gated myocardial SPECT (GSPECT) is a compromise between geometric resolution and count statistics with varying values and is rather inconsistent in different centers. We investigated the influence of typical acquisition matrix sizes for GSPECT on the reproducibility and accuracy of left ventricular function parameters using a dynamic heart phantom.
    Methods: Ten paired acquisitions, each pair with slightly different phantom positions, were obtained using identical imaging parameters except acquisition matrix: 128×128 matrix (3.3 mm voxel) and 64×64 matrix (6.6 mm voxel). In the next step, 128×128 data sets were compressed to an additional set of 64×64 matrix images.
    Results: Nominal value of left ventricular ejection fraction (LVEF) of the phantom was 67%. Both acquisition matrices led to significant overestimation of the LVEF. Overestimation was more pronounced in 64×64 than in 128×128 studies (79.8±2.5% vs. 73.6±1.4%, p<0.05). Calculated volumes were closer to the nominal values with 128×128 than with 64×64 studies. Variance showed a trend to be higher with 64×64 matrix, but the effect did not reach the level of statistical significance.
    Conclusions: LVEF overestimation and volume underestimation can be reduced by using finer matrix size without any negative effect on the reproducibility.
  • Hiroto Yoneyama, Kenichi Nakajima, Junichi Taki, Hiroshi Wakabayashi, ...
    Article type: Original Article
    2021 Volume 7 Issue 1 Pages 49-56
    Published: August 31, 2021
    Released on J-STAGE: August 31, 2021
    JOURNAL FREE ACCESS FULL-TEXT HTML
    Objective: Although semiconductor single-photon emission computed tomography (D-SPECT) has been used for myocardial perfusion imaging, few studies have compared its ability to detect myocardial ischemia with that of 3-detector SPECT (GCA9300R). This study used invasive coronary angiography to determine whether the detectability of myocardial ischemia differs between D-SPECT and GCA9300R.
    Materials and methods: This study included 24 patients who were assessed by coronary angiography within 60 days of myocardial perfusion D-SPECT and GCA9300R. Two nuclear medicine physicians interpreted myocardial perfusion D-SPECT and GCA9300R images with five grades of confidence, then defined regions of ischemia on polar maps. The gold standard was determined by another nuclear cardiology specialist based on integrated assessment of the coronary angiography findings and other clinical information derived from medical charts. The concordance rate and the Cohen kappa (κ) between D-SPECT and GCA9300R were calculated.
    Results: The sensitivity, specificity, negative and positive predictive values, and the accuracy of patient-based diagnoses were 66.7%, 91.7%, 89.2%, 72.8%, and 85.5%, respectively, for GCA9300R, and 83.3%, 83.3%, 93.7%, 62.4%, and 83.3%, respectively, for D-SPECT. Interpretations of ischemia did not uncover any significant differences between D-SPECT and GCA9300R. The Cohenκvalues of D-SPECT and GCA9300 agreed substantially, moderately and marginally for the left circumflex coronary artery (LCX) (0.68), right coronary artery (RCA) (0.43), and left anterior descending coronary artery (LAD) (0.39), respectively.
    Conclusions: The detectability of myocardial ischemia is comparable between D-SPECT and GCA9300R. Sensitivity is better for D-SPECT than GCA9300R. However, false-positive D-SPECT findings, especially in the apex and inferior wall should be interpreted with caution.
Review Articles
  • A Systematic Review
    Osamu Manabe, Tadao Aikawa, Masanao Naya, Shiro Miura, Noriko Oyama-Ma ...
    Article type: Review Article
    2021 Volume 7 Issue 1 Pages 57-62
    Published: August 31, 2021
    Released on J-STAGE: August 31, 2021
    JOURNAL FREE ACCESS FULL-TEXT HTML
    Positron emission tomography (PET) permits the noninvasive quantification of myocardial blood flow (MBF). Myocardial flow reserve (MFR), calculated by dividing stress MBF by rest MBF is a reliable index for the functional information of coronary artery disease. A pressure-derived physiological index, such as fractional flow reserve (FFR) is also an important measurement. Both MFR and FFR values are used to evaluate coronary physiology; however, but they are not interchangeable because each test has certain discrepancies.
    In this systematic review, we provide an overview of coronary physiology with PET compared to pressure-derived physiological indices.
  • Kazuya Takehana
    Article type: Review Article
    2021 Volume 7 Issue 1 Pages 63-66
    Published: August 31, 2021
    Released on J-STAGE: August 31, 2021
    JOURNAL FREE ACCESS FULL-TEXT HTML
    In recent years, the requirement for pharmacological stress myocardial perfusion imaging (SPECT) has increased, and adenosine stress testing is now the mainstream. Selective adenosine A2A receptor agonists will be applied clinically in the future. By selectively activating only A2A receptors, it can reduce complications such as bronchospasm, hypotension, and bradycardia, which have been problems with adenosine stress tests. In addition, since this drug can be administered in bolus injection, it has the advantage of being able to perform the test at one root.
Technical Point of View
  • Kozo Fujii, Yu Mizuguchi, Kento Oguri, Hideto Kitajima, Tetsuro Katafu ...
    Article type: Technical Point of View
    2021 Volume 7 Issue 1 Pages 67-72
    Published: August 31, 2021
    Released on J-STAGE: August 31, 2021
    JOURNAL FREE ACCESS FULL-TEXT HTML
    Supplementary material
    Background: The myocardial perfusion stress conducted by physicians and nurses requires two imaging sessions, one during stress and the other during rest. Echocardiography is sometimes performed before delayed imaging, and medical laboratory technicians (MLTs) have similar exposure in such cases. This study was designed to investigate the radiation exposure of physicians, nurses, radiologists, and MLTs involved in thallium-201 chloride (201TlCl) stress myocardial perfusion imaging and echocardiography, the details of which have not been reported to date.
    Methods: The dose rate at thallium-201 (201Tl) was examined using a cylindrical phantom. The exposure of physicians, nurses, and radiologists involved in the 201TlCl stress myocardial perfusion imaging was measured using pocket dosimeters, and that of the MLTs in charge of echocardiography were measured using glass-batch dosimeters.
    Results: The attenuation of radiation exposure from the phantom with distance was 95% at 50 cm from the center of the phantom, demonstrated that the attenuation of the exposure dose increased with distance. The exposure dose for physicians, nurses, and radiological technologists that participated in 201TlCl stress myocardial perfusion imaging was 0.20–0.23 μSv per exam, whereas it was 6.67–10.00 μSv per exam for MLTs.
    Conclusion: This study measured the dose received by physicians, nurses, and radiological technologists during stress MPI and the dose received by MLTs during echocardiography. The results provided advanced knowledge for the management of dose received by medical personnel.
Images in Nuclear Cardiology
  • Kyoko Oyama-Suzuki, Kenji Fukushima, Ryuta Egi, Shintaro Nakano, Toshi ...
    Article type: Images in Nuclear Cardiology
    2021 Volume 7 Issue 1 Pages 73-76
    Published: August 31, 2021
    Released on J-STAGE: August 31, 2021
    Advance online publication: June 15, 2021
    JOURNAL FREE ACCESS FULL-TEXT HTML
    A 58-year-old asymptomatic man with electrocardiogram (ECG) abnormality was referred to our institution for cardiac exams. His ECG showed a bifascicular block, and the echocardiography demonstrated a wall motion abnormality in apex. Stress-rest myocardial perfusion imaging (MPI) showed a significant defect in anterior wall with partial redistribution at rest. He was suspected of having an anterior myocardial infarction (MI) and underwent cardiac catheterization. However, coronary angiography (CAG) revealed no significant coronary atherosclerosis. Cardiovascular magnetic resonance imaging (CMR) was performed to evaluate the extent of myocardial infarction. Late gadolinium enhancement (LGE) demonstrated a significant epicardial and mid-myocardial LGE in the multiple site including anterior, anteroseptal, lateral, inferior wall, and basal right ventricle junction, which strongly indicated that the fibrosis was due to cardiac sarcoidosis (CS). A myocardial perfusion defect in anterior wall shown in the MPI revealed the fibrosis as an atypical finding mimicking anterior MI.
JSNC Annual Scientific Meeting
ASNC/JSNC Joint Symposium
Educational Track
  • Joint Symposium in JSNC 2021 and More!
    Takashi Kudo
    Article type: Review Article
    2021 Volume 7 Issue 1 Pages 82-85
    Published: August 31, 2021
    Released on J-STAGE: August 31, 2021
    JOURNAL FREE ACCESS FULL-TEXT HTML
    The Japanese Society of Nuclear Cardiology (JSNC) and the American Society of Nuclear Cardiology (ASNC) has a cooperative relationship through a memorandum of understanding (MOU), based on which we hold a joint symposium in the JSNC annual meeting in early summer. In addition to the joint symposium this year, a joint webinar was held in early June. The theme of the joint symposium and webinar was cardiac amyloidosis. We consider the success of this collaborative work to be the fruit of the close friendship between JSNC and ASNC. The cooperative relationship between JSNC and ASNC will continue to grow.
Memoriam
feedback
Top